Page last updated: 2024-10-24

chlorambucil and Intestinal Obstruction

chlorambucil has been researched along with Intestinal Obstruction in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Intestinal Obstruction: Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ENGLE, I1
AAKHUS, T1
Clark, DG1
Hilaris, BS1
Ochoa, M1
Freel, JH1

Other Studies

2 other studies available for chlorambucil and Intestinal Obstruction

ArticleYear
INTESTINAL OBSTRUCTION IN MYCOSIS FUNGOIDES.
    The British journal of radiology, 1965, Volume: 38

    Topics: Chlorambucil; Drug Therapy; Humans; Intestinal Neoplasms; Intestinal Obstruction; Mycosis Fungoides;

1965
Interdisciplinary approach to advanced ovarian cancer.
    The Surgical clinics of North America, 1974, Volume: 54, Issue:4

    Topics: Alkylating Agents; Ascites; Chlorambucil; Dactinomycin; Drug Therapy, Combination; Female; Fluoroura

1974